XWPharma employs the following strategies across all of our programs to increase the odds that our internally discovered medicines will succeed in clinical testing and commercialization.
- We focus our propriety drug discovery methodology on mechanisms of action that are validated as highly effective in clinical studies and medical practice.
- Our investigational drug therapies aim to leverage time-regulated neurobiology to achieve efficacy without the limitations associated with currently available treatments.
- We pursue efficient development pathways that are designed to de-risk each program at an early stage of clinical development.
- Each therapy targets high value commercial markets with favorable reimbursement and market access.
- All our therapies in clinical development are new chemical entities with distinctive features and composition of matter intellectual property.